Literature DB >> 21852019

Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?

Sally Johnson1, Aoife Waters.   

Abstract

Haemolytic uraemic syndrome (HUS) accounts for the most common cause of childhood acute renal failure. Characterized by the classical triad of a microangiopathic haemolytic anaemia, thrombocytopaenia and acute renal failure, HUS occurs as a result of Shiga-toxin producing microbes in 90% of cases. The remaining 10% of cases represent a heterogeneous subgroup in which inherited and acquired forms of complement dysregulation have been described in up to 60%. Emerging evidence suggests that microbes associated with HUS exhibit interaction with the complement system. With the advent of improved genetic diagnosis, it is likely that certain cases of infection-induced HUS may be attributed to underlying defects in complement components. This review summarises the interplay between complement and infection in the pathogenesis of HUS.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852019     DOI: 10.1016/j.imbio.2011.07.022

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 2.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

3.  Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.

Authors:  Silvia Ehrlenbach; Alejandra Rosales; Wilfried Posch; Doris Wilflingseder; Martin Hermann; Jens Brockmeyer; Helge Karch; Simon C Satchell; Reinhard Würzner; Dorothea Orth-Höller
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 4.  Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.

Authors:  Lindsay S Keir; Moin A Saleem
Journal:  Pediatr Nephrol       Date:  2013-07-11       Impact factor: 3.714

Review 5.  New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome.

Authors:  Tania N Petruzziello-Pellegrini; Mozhgan Moslemi-Naeini; Philip A Marsden
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

6.  Thrombotic Microangiopathy Secondary to Disseminated Varicella Zoster Virus Infection in an Adult Patient.

Authors:  Neama Luqman; Rama Bakie; Waqar H Gaba; Syed Athar
Journal:  Am J Case Rep       Date:  2022-08-23

Review 7.  Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.

Authors:  Hemant S Agarwal; Samir Q Latifi
Journal:  Pathogens       Date:  2021-06-09

8.  Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3.

Authors:  Callum N Watson; Steven W Kerrigan; Dermot Cox; Ian R Henderson; Steve P Watson; Mònica Arman
Journal:  Platelets       Date:  2016-03-30       Impact factor: 3.862

9.  Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors:  Vicky Brocklebank; David Kavanagh
Journal:  Clin Kidney J       Date:  2017-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.